Better access to healthcare equals better health outcomes. Biogen strives to increase access and address the barriers that patient populations face. Oftentimes, health outcomes...
The devastating impact of the COVID-19 pandemic, particularly on communities of color, has been a painful reminder of the racial and ethnic disparities that...
By: Luther T. Clark, MD, Deputy Chief Patient Officer, Merck
Barriers to participation of racially and ethnically underrepresented patients in clinical trials include: (1) mistrust,...
The FDA recently showcased the demographic characteristics of study volunteers in clinical trials for drugs that gained approval in 2019. Of the 46,391 participants,...
The importance of clinical research is widely recognized and while many decide to participate in clinical trials, there is a lack of representation of...
